What is the recommended treatment for hot flashes in a 65-year-old postmenopausal woman like Tresa?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Hot Flashes in a 65-Year-Old Postmenopausal Woman

For a 65-year-old postmenopausal woman like Tresa experiencing hot flashes, venlafaxine (SNRI) at 75 mg daily is the recommended first-line non-hormonal pharmacologic treatment due to its demonstrated efficacy and favorable side effect profile. 1, 2

First-Line Pharmacologic Options

SNRIs

  • Venlafaxine: Start at 37.5 mg/day and titrate to optimal dose of 75 mg/day
    • Reduces hot flash score by 61% (compared to 27% with placebo) 1
    • Faster onset of action compared to other options 1
    • Side effects: dry mouth, decreased appetite, nausea, constipation (dose-related) 1
    • Requires gradual tapering when discontinuing to prevent withdrawal symptoms 1

SSRIs

  • Paroxetine: 7.5-12.5 mg daily (controlled release)

    • Reduces hot flash composite score by 62% 1
    • Caution: Avoid in women taking tamoxifen due to CYP2D6 inhibition 1, 2
  • Citalopram: Alternative for those who don't respond to venlafaxine 1, 2

    • Minimal effect on tamoxifen metabolism 1
    • Variable response with 42% of women improving by >50%, but 27% experiencing worsening symptoms 1

Second-Line Options

Anticonvulsants

  • Gabapentin: Particularly useful for nighttime hot flashes
    • Reduces hot flash severity score by 46% at 8 weeks (vs 15% with placebo) 1
    • Side effect of somnolence makes it ideal for bedtime dosing 1
    • May be less preferred than venlafaxine (68% of patients prefer venlafaxine over gabapentin) 1

Alpha-Agonists

  • Clonidine: Consider if other options are contraindicated
    • Reduces hot flashes in a dose-dependent manner 1
    • Side effects: sleep difficulties, dry mouth, fatigue, dizziness, nausea 1
    • Less well-tolerated than venlafaxine 1

Non-Pharmacologic Approaches

Lifestyle Modifications

  • Avoid triggers: spicy foods, caffeine, alcohol 2
  • Environmental changes: cool rooms, dressing in layers 2
  • Weight loss if overweight (10% weight loss can eliminate symptoms) 2

Alternative Therapies

  • Acupuncture: Studies show equivalence or superiority to drug treatments 1, 2
  • Cognitive Behavioral Therapy (CBT): Reduces perceived burden of hot flashes 2
  • Relaxation techniques: Slow-breathing exercises, hypnosis 2
  • Yoga: May improve quality of life but mixed results for direct hot flash reduction 1, 2

Treatment Algorithm

  1. Start with venlafaxine 37.5 mg daily for 1 week
  2. If tolerated, increase to 75 mg daily (optimal dose)
  3. If ineffective or poorly tolerated after 4 weeks, switch to:
    • Citalopram (if no tamoxifen use), OR
    • Gabapentin (especially for nighttime symptoms), OR
    • Consider non-pharmacologic approaches

Important Considerations

  • Doses of antidepressants for hot flashes are typically lower than those needed for depression 1, 2
  • Response is typically faster than when used for depression 1
  • Placebo effect is considerable (25% or more) 1
  • Individual response varies significantly - some women have vigorous response, others modest, and some worsen with treatment 3
  • Meta-analyses show SSRIs provide modest but statistically significant improvement in hot flash frequency and severity 4

Pitfalls to Avoid

  • Do not use paroxetine or fluoxetine in women taking tamoxifen due to interference with tamoxifen metabolism 1, 2
  • Do not use black cohosh due to lack of proven benefit and reports of liver failure 2
  • Avoid abrupt discontinuation of SNRIs/SSRIs; taper gradually to prevent withdrawal symptoms 1
  • Monitor for side effects of SNRIs, including potential blood pressure elevation 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Menopausal Symptom Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.

The Journal of the Oklahoma State Medical Association, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.